Diana Z. Ye, Klaus H. Kaestner  Gastroenterology 

Slides:



Advertisements
Similar presentations
Volume 131, Issue 2, Pages (August 2006)
Advertisements

Volume 141, Issue 6, Pages e7 (December 2011)
Volume 140, Issue 5, Pages e10 (May 2011)
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 135, Issue 5, Pages e24 (November 2008)
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Volume 131, Issue 2, Pages (August 2006)
Volume 133, Issue 6, Pages (December 2007)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 5, Pages e1 (November 2011)
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Yingben Xue, James C. Fleet  Gastroenterology 
Volume 137, Issue 2, Pages (August 2009)
Volume 141, Issue 5, Pages (November 2011)
Volume 134, Issue 2, Pages (February 2008)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 120, Issue 5, Pages (April 2001)
Volume 137, Issue 1, Pages e3 (July 2009)
Transcription Factor Foxq1 Controls Mucin Gene Expression and Granule Content in Mouse Stomach Surface Mucous Cells  Michael P. Verzi, Abdul H. Khan,
Volume 142, Issue 3, Pages (March 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 146, Issue 3, Pages e3 (March 2014)
Volume 139, Issue 6, Pages e2 (December 2010)
Current View: Intestinal Stem Cells and Signaling
Volume 132, Issue 5, Pages (May 2007)
Volume 139, Issue 3, Pages (September 2010)
Nan Gao, Peter White, Klaus H. Kaestner  Developmental Cell 
Volume 155, Issue 2, Pages (August 2018)
Volume 133, Issue 3, Pages (September 2007)
Peptide YY Regulates Bone Turnover in Rodents
Volume 128, Issue 4, Pages (April 2005)
Volume 136, Issue 7, Pages e7 (June 2009)
Volume 137, Issue 1, Pages e3 (July 2009)
Volume 133, Issue 6, Pages (December 2007)
Volume 122, Issue 2, Pages (February 2002)
Volume 137, Issue 4, Pages (October 2009)
Volume 133, Issue 3, Pages (September 2007)
Volume 128, Issue 7, Pages (June 2005)
Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice  Helen H. Wang, Nezam H. Afdhal, Sandra J. Gendler,
Volume 11, Issue 1, Pages (April 2015)
Reserve Stem Cells in Intestinal Homeostasis and Injury
Volume 153, Issue 4, Pages e4 (October 2017)
Volume 135, Issue 3, Pages e6 (September 2008)
GATA4 Is Essential for Jejunal Function in Mice
Volume 133, Issue 4, Pages (October 2007)
Volume 140, Issue 5, Pages e10 (May 2011)
Singling Out Intestinal Epithelial Stem Cells
Volume 130, Issue 4, Pages (April 2006)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 145, Issue 6, Pages e4 (December 2013)
Volume 131, Issue 2, Pages (August 2006)
Volume 139, Issue 1, Pages (July 2010)
Volume 134, Issue 4, Pages (April 2008)
Suppression of Apoptosis, Crypt Hyperplasia, and Altered Differentiation in the Colonic Epithelia of Bak-Null Mice  Carrie A. Duckworth, D. Mark Pritchard 
Volume 133, Issue 2, Pages (August 2007)
Volume 132, Issue 7, Pages (June 2007)
The role of transforming growth factor beta-2, beta-3 in mediating apoptosis in the murine intestinal mucosa  Nicole Dünker, Kai Schmitt, Norbert Schuster,
Volume 139, Issue 3, Pages e6 (September 2010)
Volume 130, Issue 3, Pages (March 2006)
Volume 10, Issue 1, Pages (January 2018)
Volume 137, Issue 1, Pages e3 (July 2009)
Volume 140, Issue 4, Pages e2 (April 2011)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 138, Issue 3, Pages e5 (March 2010)
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Volume 138, Issue 5, Pages e5 (May 2010)
Volume 2, Issue 2, Pages (February 2014)
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 139, Issue 3, Pages (September 2010)
Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling   Ali Moussavi Nik, Azadeh Reyahi,
Presentation transcript:

Foxa1 and Foxa2 Control the Differentiation of Goblet and Enteroendocrine L- and D- Cells in Mice  Diana Z. Ye, Klaus H. Kaestner  Gastroenterology  Volume 137, Issue 6, Pages 2052-2062 (December 2009) DOI: 10.1053/j.gastro.2009.08.059 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Reduced body weight and slower growth rate in mice with intestine-specific deletion of Foxa1 and Foxa2. (A) Scheme for generation of mice with intestine-specific deletion of Foxa1 and Foxa2. Two loxP sites were inserted to flank exon 2 of Foxa1 or exon 3 of Foxa2. Villin-cre transgenic mice were used to achieve intestine-specific deletion. (B) qRT-PCR showed that Foxa3 expression was unchanged in the duodenum (d) but decreased in the jejunum (j) of Foxa1,Foxa2;villin-cre mice (Foxa1/a2 mutants) (n = 4, male). (C) Growth rate of Foxa1/a2 mutants was lower than controls (n = 4, male). (D) Dual-energy x-ray absorptiometry scan showed that Foxa1/a2 mutants have lower bone mineral content (bmc), lean muscle, and whole body fat (n = 4, male). (E) Representative image of immunohistochemical analysis showing that Foxa1 and Foxa2 were deleted in the ileum of Foxa1/a2 mutants (n = 4, male). All the qRT-PCR results were normalized to the expression of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase. Data are means ± SE. *P < .05, **P < .01 vs controls. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Defective goblet cell differentiation in Foxa1/a2 mutants. (A) Alcian blue staining of jejunum, colon, and rectum. Foxa1/a2 mutant mice have a progressive decrease of the number of goblet cells (blue) along the small intestine, colon, and rectum. (B) The number of goblet cells was counted in the duodenum, jejunum, and ileum (n = 4, male). Data are means ± SE. *P < .05 vs controls. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Reduced mucin granules in goblet cells of Foxa1/a2 mutants. Representative image of electron microscopy analysis showing decreased mucin granules in colon and rectum goblet cells of Foxa1/a2 mutants (n = 2, male). Red arrows indicate vacuoles with complete or partial loss of mucin granules. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Defective goblet cell differentiation in Foxa1/a2 mutants. qRT-PCR was performed to measure mRNA levels of (A) Muc2, (B) Muc5b, (C) Muc5ac, and (D) Muc6. Muc2 and Muc6 mRNA levels were reduced significantly in the colon and rectum of Foxa1/a2 mutants compared with controls. Muc5b and Muc5ac mRNA levels were increased significantly in the colon and rectum of Foxa1/a2 mutants compared with controls. All qRT-PCR results were normalized to the expression of hypoxanthine phosphoribosyltransferase. (E) Top panel: putative Foxa binding site in the Muc2 promoter as predicted by JASPAR. Lower panel: a gel representation of Muc2 promoter enrichment after ChIP with Foxa1 antibody. The myelin basic protein (mbp) gene was used as a nonspecific control. (F) qRT-PCR analysis of ChIP performed using Foxa1 or Foxa2 antibody. Enrichment of the Muc2 promoter was calculated by using MBP. Foxa1 is the preferred transcription factor for binding to the Muc2 promoter. Data are means ± SE. *P < .05, **P < .01 vs controls. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Decreased enteroendocrine cell differentiation in Foxa1 and Foxa2 mutants. Immunohistochemical analysis of duodenum, jejunum, and ileum with an antibody against chromogranin A. The number of chromogranin A–positive cells was decreased in Foxa1/a2 mutants compared with controls. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Decreased differentiation of L- and D-cells in Foxa1/a2 mutants. Immunohistochemical staining was performed using antibodies against Glp-1, Glp-2, somatostatin, or PYY. Glp-1– and Glp-2–positive cells (brown and arrow) were absent from the ileum of Foxa1/a2 mutants (20×). Somatostatin (sst)-positive cells (brown and arrow) were reduced in the jejunum of Foxa1/a2 mutants (20×). PYY-positive cells (brown and arrow) were reduced in the ileum of Foxa1/a2 mutants (20×). Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 7 Isl-1 and Pax6 act downstream of Foxa1 and Foxa2 in the enteroendocrine cell lineage. qRT-PCR was performed to measure mRNA levels of (A) preproglucagon, (B) somatostatin, (C) PYY (n = 4, male). Preproglucagon and somatostatin mRNA levels were decreased significantly in the duodenum and jejunum of Foxa1/a2 mutants. The PYY mRNA level was decreased significantly in the ileum of Foxa1/a2 mutants. (D) qRT-PCR was performed to measure mRNA levels of Isl-1, Ngn3, and Beta2. Isl-1 expression was reduced significantly whereas Ngn-3 and Beta2 mRNA levels were not altered. (E) qRT-PCR was performed to measure mRNA levels of Pax6 and Pax4. Pax6 mRNA expression was decreased significantly but Pax4 expression was unchanged (n = 4, male). Data are means ± SE. *P < .05, **P < .01 vs controls. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions

Figure 8 Proposed model for the role of Foxa1 and Foxa2 during differentiation of the secretory cell lineage in the mammalian intestine. During the process of intestinal epithelial cell regeneration, stem cells located in the crypts divide to generate multiple cell lineages. Secretory cell lineages derive from a common progenitor expressing Math1.6 Ngn3 controls enteroendocrine cell fate commitment of Math-1–positive progenitors of the secretory lineage.1 Beta2 acts downstream of Ngn3 and is required specifically for differentiation of CCK- and secretin (sec)-producing cells.1 The present study showed that Foxa1 and Foxa2 act downstream of Ngn3 in the enteroendocrine cell lineage. We propose that Isl-1, Pax4, and Pax6 act downstream of Foxa1/Foxa2 to regulate the L- and D-cell differentiation. Moreover, Foxa1 and Foxa2 also are critical for goblet cell differentiation and function. Gastroenterology 2009 137, 2052-2062DOI: (10.1053/j.gastro.2009.08.059) Copyright © 2009 AGA Institute Terms and Conditions